相关实验视频

Updated: Jun 3, 2025

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma

Published on: July 25, 2011

探索头癌中的PANoptosis:一种新的癌症治疗方法

Li Wang¹, Baisheng Lin¹, Feixiang Wang²

¹Department of Radiation Oncology, Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, China.

Ecotoxicology and environmental safety

|January 7, 2025

概括

这项研究揭示了内分泌干扰化学物质 (EDC) 如何通过PANoptosis基因影响头支状细胞癌 (HNSC). 它识别了关键的基因和EDCs,为HNSC病变发生提供了新的见解.

科学领域:

在瘤学瘤学.
细胞死亡研究细胞死亡研究
环境健康环境健康

背景情况:

复杂的编程细胞死亡 (PCD) 途径PANoptosis,通过影响瘤存活率和治疗反应,在癌症治疗中至关重要.
已知内分泌干扰化学物质 (EDC) 影响癌症的发展,但它们在通过PANoptosis基因对头角状细胞癌 (HNSC) 的特定作用尚未得到充分研究.

研究的目的:

研究HNSC.中EDC与PANoptosis相关基因之间的关联.
开发基于PANoptosis基因的HNSC预测风险模型.
为了识别新的EDC和关键基因涉及HNSC病变发生.

主要方法:

利用了TCGA和GEO数据库中的转录和临床数据,用于HNSC.
应用LASSO考克斯回归分析来构建一个使用PANoptosis相关基因的风险模型.
采用桑基图来可视化EDC与已识别的关键基因 (DSCAM,IL-6,SYCP2) 之间的关系.

主要成果:

开发了一个风险模型,确定DSCAM,IL-6和SYCP2作为HNSC中PANoptosis的关键预测因素.
发现有214种EDC可能影响HNSC,其中包括三种以前未报告的 (Aroclor 1242,Pentachlorobenzene,Propanil).
在EDC介导的PANoptosis路径和HNSC发育之间建立了新的联系.

结论:

DSCAM,IL-6和SYCP2是HNSC中关键的PANoptosis相关基因,受到各种EDC的影响.
这项研究强调了以前未被认可的EDCs影响HNSC,并提出了新的治疗和预防策略.
这些发现提供了对环境因素,细胞死亡机制和HNSC病原体之间的相互作用的更深入的理解.

关键词:

破坏内分泌的化学物质破坏内分泌的化学物质头癌是头部和部的癌症.免疫治疗是一种免疫疗法.这就是PANoptosis.瘤微环境是一个微环境.

更多相关视频

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

相关概念视频

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...